UFP Technologies Inc (UFPT)
262.14
+6.86
(+2.69%)
USD |
NASDAQ |
May 03, 16:00
261.68
-0.46
(-0.18%)
After-Hours: 20:00
UFP Technologies Enterprise Value: 2.033B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 2.033B |
May 02, 2024 | 1.981B |
May 01, 2024 | 1.832B |
April 30, 2024 | 1.602B |
April 29, 2024 | 1.730B |
April 26, 2024 | 1.658B |
April 25, 2024 | 1.631B |
April 24, 2024 | 1.667B |
April 23, 2024 | 1.659B |
April 22, 2024 | 1.657B |
April 19, 2024 | 1.617B |
April 18, 2024 | 1.693B |
April 17, 2024 | 1.753B |
April 16, 2024 | 1.764B |
April 15, 2024 | 1.777B |
April 12, 2024 | 1.779B |
April 11, 2024 | 1.770B |
April 10, 2024 | 1.833B |
April 09, 2024 | 1.924B |
April 08, 2024 | 1.958B |
April 05, 2024 | 1.943B |
April 04, 2024 | 1.935B |
April 03, 2024 | 1.920B |
April 02, 2024 | 1.915B |
April 01, 2024 | 1.939B |
Date | Value |
---|---|
March 31, 2024 | 1.950B |
March 28, 2024 | 1.954B |
March 27, 2024 | 1.954B |
March 26, 2024 | 1.866B |
March 25, 2024 | 1.831B |
March 22, 2024 | 1.896B |
March 21, 2024 | 1.841B |
March 20, 2024 | 1.754B |
March 19, 2024 | 1.665B |
March 18, 2024 | 1.508B |
March 15, 2024 | 1.505B |
March 14, 2024 | 1.494B |
March 13, 2024 | 1.521B |
March 12, 2024 | 1.519B |
March 11, 2024 | 1.504B |
March 08, 2024 | 1.555B |
March 07, 2024 | 1.605B |
March 06, 2024 | 1.611B |
March 05, 2024 | 1.588B |
March 04, 2024 | 1.676B |
March 01, 2024 | 1.684B |
February 29, 2024 | 1.619B |
February 28, 2024 | 1.618B |
February 27, 2024 | 1.600B |
February 26, 2024 | 1.674B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
229.34M
Minimum
Mar 18 2020
2.033B
Maximum
May 03 2024
680.02M
Average
470.04M
Median
Enterprise Value Benchmarks
Integer Holdings Corp | 4.827B |
ICU Medical Inc | 3.788B |
LeMaitre Vascular Inc | 1.553B |
ResMed Inc | 32.64B |
Perspective Therapeutics Inc | 1.055B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 12.69M |
Revenue (Quarterly) | 105.01M |
Total Expenses (Quarterly) | 88.84M |
EPS Diluted (Quarterly) | 1.64 |
Gross Profit Margin (Quarterly) | 28.65% |
Profit Margin (Quarterly) | 12.09% |
Earnings Yield | 2.37% |
Operating Earnings Yield | 3.06% |
Normalized Earnings Yield | 2.417 |